RecruitingMenopausePerimenopause
Effects of Hemp-Derived Cannabinoids on Menopause Symptoms
Eligible age
40–60 yrs
Accepts
Women
Locations
1 state
Healthy volunteers
Yes
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of the study is to examine the impact of hemp-derived minor cannabinoids on symptoms of menopause/perimenopause.
Sponsor: Washington State University
You may qualify if…
- ✓ designated female at birth
- ✓ 40-60 years of age
- ✓ able to give informed consent (no intellectual disability)
- ✓ stable pharmacotherapeutic regimen, no change in the past 3 months
- ✓ abstinent from regular cannabis use (\<1x/month) for past year, and willing to abstain from use for 3 months
- ✓ abstinent for supplements, don't add any supplements (no changes in past 3 months)
- ✓ own a smartphone
- ✓ have access to Zoom on a secure, stable internet connection
You may not qualify if…
- ✕ currently taking anti-depressant, anti-anxiety, and/or antipsychotic medication
- ✕ severe depression, neurovegetative symptoms, or current suicidality
- ✕ psychosis or family history of psychosis
- ✕ pregnant or breastfeeding
- ✕ chemotherapy
- ✕ hypotension
- ✕ drug testing for work or other reasons
- ✕ illicit drug use in past 3 months (cannabis not illicit)
Where it's recruiting
Washington
Pullman
Source: ClinicalTrials.gov · NCT07393672 · last updated 2026-03-10